MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)
Clinical trial NCT05650918 · COMPLETED
Trial details
- NCT number
- NCT05650918
- Sponsor
- Joachim Aerts, MD PhD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-30
- Primary completion
- 2023-05-23
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.